A lot of software comes out for Mac and Windows these days, but there are always a few games or apps that don't make it OS X. Thankfully, you can easily port many Windows programs to OS X with a free ...

I've been installing all my programs other than MS Office and Drivers to a separate SSD from my C drive. I've never done this before so forgive my ignorance but, if I install Windows from scratch on ...

As we discuss Apple’s new operating system, there’s a strong awareness that, no matter how good Mac OS X itself might be, it can’t succeed without applications created outside Apple. As a result, ...

Mac only: Wine has always been popular among Linux users for running Windows programs, but Wine is available for Mac, too—and now, free utility WineBottler can "bottle" Windows programs into separate ...

For years now, Google has been developing Fuchsia, an operating system that is distinctly not based on Linux. The latest proposal for Fuchsia OS shows how this “not Linux” operating system could run ...

The first stable version of Qubes OS, an open source desktop operating system designed to provide a greater level of security by isolating programs inside virtual machines with different permissions, ...

OS Therapies (OSTX) announced it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology programs and related intellectual property assets from Ayala ...

NEW YORK, January 29, 2025--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, ...

NEW YORK--(BUSINESS WIRE)-- OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it ...

NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced it has ...

Consolidates ownership of listeria monocytogenes-based immunotherapy IP Eliminates milestone payments and reduces future royalty obligations relating to OST-HER2 for osteosarcoma and other ...